Medicus Pharma (MDCX) Stock: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.17
0.01 (5.34%)
â˛
5d:
+11.51%
30d:
-0.53%
90d:
-61.45%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MDCX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MDCX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.17, which is considered slightly low relative to its 30-day fair value range of $0.14 to $0.22.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.15, while resistance sits at $0.18. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.50 (+2695.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.15, while resistance sits at $0.18. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.50 (+2695.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.14 -
$0.22
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (56/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 2695.0% below Wall St target ($4.50)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.14 -
$0.22
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.15
Resistance Level
$0.18
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.55
Wall Street Target
$4.50
(+2695.0%)
Share & Embed Analysis
Last updated: October 05, 2026 1:31 PM ET
Data refreshes hourly during market hours. Next update: 2:31 PM
Data refreshes hourly during market hours. Next update: 2:31 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
30 analysts |
$279 | 60 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
30 analysts |
$1329 | 42 HOLD |
|
BIIB
Biogen Inc |
BUY
35 analysts |
$238 | 54 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
27 analysts |
$159 | 45 HOLD |
|
MRK
Merck & Company Inc |
STRONG BUY
27 analysts |
$156 | 50 HOLD |
